Posts

The ADC Cytotoxic Payloads / Warheads market

Image
  The “ ADC Cytotoxic Payloads / Warheads market, 2021-2030” report features an extensive study on the current market landscape, offering an informed opinion on the likely future potential of ADC Cytotoxic Payloads / Warheads service providers, over the next decade.   To order this 130+ page report, please visit https://www.rootsanalysis.com/reports/adc-cytotoxic-payloads-market.html   Key Inclusions §   A review of the overall market landscape of the companies offering ADC payloads and warheads, featuring a detailed analysis based on the type of payload, type of microtubule inhibitors, DNA damaging agents and toposimerase inhibitors . In addition, it includes information on the developer’s year of establishment, and location of headquarters and company size of the players. §   Elaborate profiles of players involved in the manufacturing of ADC payloads and warheads. Each profile features a brief overview of the company, its facility location, its financial information

The Companion Diagnostics Development Services Market

Image
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Companion Diagnostics Development Services Market, 2020-2030 ”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes: §   A detailed assessment of the current market landscape of more than 180 companies offering companion diagnostics services. §   Tabulated profiles of companion diagnostics service providers (shortlisted on the basis of the number of services offered)

The antibody contract manufacturing market

Image
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone   Roots Analysis has announced the addition of the “ Antibody Contract Manufacturing Market, 2020-2030 ” report to its list of offerings.   Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturi